Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 1991-1996

  Huang, Kai Wen ^a   Yang, Shieh Yueh ^b,c   Hong, Yu Wei ^c   Chieh, Jen Jie ^c   Yang, Che Chuan ^c   Horng, Herng Er ^c   Wu, Chau Chung ^d   Hong, Chin Yih ^e   Yang, Hong Chang ^f  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MAGQU CO LTD   (Taiwan)

^c NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Biofunctionalized magnetic nanoparticles; ELISA; Immunomagnetic reduction

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; HEMOGLOBIN; MAGNETIC NANOPARTICLE; TRIACYLGLYCEROL; VASCULOTROPIN; AFP PROTEIN, HUMAN; IMMOBILIZED ANTIBODY; MAGNETITE NANOPARTICLE;

ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER DIAGNOSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FEASIBILITY STUDY; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOASSAY; LIVER CELL CARCINOMA; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BLOOD ANALYSIS; CHEMISTRY; COMPARATIVE STUDY; IMMUNOLOGY; LIMIT OF DETECTION; LIVER TUMOR; METHODOLOGY; NANOMEDICINE; REFERENCE VALUE;

ALPHA-FETOPROTEINS; ANTIBODIES, IMMOBILIZED; BLOOD CHEMICAL ANALYSIS; CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDIES; HUMANS; LIMIT OF DETECTION; LIVER NEOPLASMS; MAGNETITE NANOPARTICLES; NANOMEDICINE; REFERENCE VALUES;

EID: 84866747613     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S28245     Document Type: Article

References (12)

1. Allan JC, Mencos F, Garcia-Noval J, et al. Dipstick dot ELISA for the detection of Taenia coproantigens in humans. Parasitol. 1993;107:79-85.
2. Mize TH, Taban I, Duursma M, et al. A modular data and control system to improve sensitivity, selectivity, speed of analysis, ease of use, and transient duration in an external source FTICR-MS. Intl J Mass Spect. 2004;235(3):243-253.
3. Li M, Alnouti Y, Leverence R, et al. Increase of the LC-MS/MS sensitivity and detection limits using on-line sample preparation with large volume plasma injection. J Chrom B. 2005;825(2):152-160.
4. Wu CM, Jian ZC, Joe SF, Chang LB. High-sensitivity sensor based on surface plasmon resonance and heterodyne interferometry. Sens Actu B Chem. 2003;92(1-2):133-136.
5. Hong CY, Wu CC, Chiu YC, et al. Magnetic susceptibility reduction method for magnetically labeled immunoassay. Appl Phys Lett. 2006;88(21):212512-1-3.
6. Rothacker J, Ramsay RG, Ciznadija D, et al. A novel magnetic bead-based assay with high sensitivity and selectivity for analysis of telomerase in exfoliated cells from patients with bladder and colon cancer. Electrophoresis. 2007;28(23):4435-4446.
7. Silva EC, Gusmão LAP, Barbosa CRH, et al. High sensitivity giant magnetoimpedance (GMI) magnetic transducer: magnitude versus phase sensing. Meas Sci Technol. 2011;22(3):35204-35208.
8. Hong CY, Chen WH, Jian ZF, et al. Wash-free immunomagnetic detection for serum through magnetic susceptibility reduction. Appl Phys Lett. 2007;90(7):74105-1-3.
9. Yang SY, Jian ZF, Chieh JJ, et al. Wash-free, antibody-assisted magnetoreduction assays on orchid viruses. J Virol Methods. 2008; 149(2):334-337.
10. Yang SY, Chieh JJ, Wang WC, et al. Magnetic nanoparticles for highsensitivity detection on nucleic acids via superconducting-quantuminterference-device-based immunomagnetic reduction assay. J Magn Magn Mater. 2011;323(6):681-685.
11. Yang SY, Jian ZF, Horng HE, et al. Dual immobilization and magnetic manipulation of magnetic nanoparticles. J Magn Magn Mater. 2008;320(21):2688-2691.
12. Yang SY, Wang WC, Lan CB, et al. Magnetically enhanced high-specificity virus detection using bio-activated magnetic nanoparticles with antibodies as labeling markers. J Virol Methods. 2010;164(1-2):14-18.